Loading the section…

DHC: financial statements from SEC — TradeAlmanac

DHC

Diversified Healthcare Trust - Common Shares of Beneficial Interest: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	366M	389M	383M	387M	374M	371M
Selling, general and administrative	14M	13M	11M	9M	14M	6M
Operating expenses	371M	498M	421M	430M	416M	387M
Pre-tax income	−43M	−169M	−94M	−10M	−99M	−85M
Income tax	622,000	337,000	843,000	49,000	148,000	170,000
Net income	−43M	−164M	−92M	−9M	−99M	−98M
Earnings per share	−0.18	−0.68	−0.38	−0.04	−0.41	−0.41
Earnings per share, diluted	−0.18	−0.68	−0.38	−0.04	−0.41	−0.41
Weighted average shares	241M	240M	240M	240M	240M	239M
Weighted average shares, diluted	241M	240M	240M	240M	240M	239M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	122M	105M	201M	142M	303M	145M	257M	266M
Total assets	4.27B	4.36B	4.68B

Cash flow

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Operating cash flow	8M	—	—	−3M	—	—
Depreciation and amortisation	63M	65M	66M	68M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator